Key Events This Week
2 Feb: Stock opens at ₹764.75, up 0.72% despite Sensex decline
3 Feb: Gains accelerate to 1.65% as Sensex rebounds strongly
4 Feb: Sharp 6.43% jump following technical upgrade and strong volume
5 Feb: Slight dip of 0.35% amid mixed technical signals
6 Feb: Week closes at ₹824.35, marginally down 0.02% on the day
2 February 2026: Resilient Start Amid Broader Market Weakness
Novartis India Ltd began the week on a positive note, closing at ₹764.75, up 0.72% from the previous Friday’s close of ₹759.30. This gain was notable as the Sensex declined by 1.03% to 35,814.09, reflecting broader market weakness. The stock’s resilience suggested early investor interest despite sector headwinds and set the tone for the week’s upward trajectory.
3 February 2026: Accelerated Gains as Market Sentiment Improves
The stock advanced further to ₹777.40, a 1.65% increase, supported by a strong rebound in the Sensex which surged 2.63% to 36,755.96. Volume increased to 4,791 shares, indicating growing participation. This day’s performance aligned with improving market sentiment and hinted at strengthening technical momentum for Novartis India.
4 February 2026: Technical Upgrade Sparks Sharp Rally
On 4 February, Novartis India Ltd experienced a significant price jump of 6.43%, closing at ₹827.40 on heavy volume of 34,985 shares. This surge followed MarketsMOJO’s upgrade of the stock’s rating from 'Strong Sell' to 'Sell', citing improvements in technical indicators despite ongoing financial challenges. The intraday high reached ₹841.65, marking a key resistance test within the stock’s 52-week range of ₹744.95 to ₹1,099.90.
The upgrade reflected a shift in technical momentum from bearish to mildly bearish, with weekly MACD and KST indicators turning mildly bullish, while monthly indicators remained cautious. This nuanced outlook contributed to the stock’s strong short-term performance, signalling a potential stabilisation phase.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
5 February 2026: Mixed Technical Signals Temper Gains
The stock retreated slightly by 0.35% to close at ₹824.50 on moderate volume of 5,130 shares. This minor dip followed the previous day’s sharp rally and coincided with mixed technical signals. While weekly indicators such as MACD and Dow Theory remained mildly bullish, monthly RSI and MACD continued to reflect bearish momentum. Daily moving averages also suggested short-term resistance near current price levels.
Despite the pullback, the stock maintained a strong position relative to the Sensex, which declined 0.53% to 36,695.11. The technical upgrade and improved momentum continued to support investor interest, though caution prevailed amid ongoing fundamental challenges.
6 February 2026: Week Closes Steady with Marginal Decline
Novartis India Ltd ended the week at ₹824.35, virtually unchanged from the previous day with a negligible 0.02% decline on increased volume of 6,354 shares. The Sensex closed slightly higher by 0.10% at 36,730.20. The stock’s ability to hold near its weekly highs despite mixed technical signals and subdued institutional interest highlighted a tentative stabilisation in price action.
Overall, the week’s 8.57% gain outpaced the Sensex’s 1.51% rise, underscoring Novartis India’s relative strength amid sector volatility and financial headwinds.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-02 | Rs.764.75 | +0.72% | 35,814.09 | -1.03% |
| 2026-02-03 | Rs.777.40 | +1.65% | 36,755.96 | +2.63% |
| 2026-02-04 | Rs.827.40 | +6.43% | 36,890.21 | +0.37% |
| 2026-02-05 | Rs.824.50 | -0.35% | 36,695.11 | -0.53% |
| 2026-02-06 | Rs.824.35 | -0.02% | 36,730.20 | +0.10% |
Key Takeaways
Positive Signals: Novartis India’s 8.57% weekly gain significantly outperformed the Sensex’s 1.51%, driven by a technical upgrade from 'Strong Sell' to 'Sell' and improved momentum indicators on weekly charts. The stock’s intraday high of ₹841.65 demonstrated strong buying interest, supported by a surge in volume on 4 February. The company’s low debt-to-equity ratio and robust long-term operating profit growth (CAGR 57.68%) provide a foundation for financial stability despite recent quarterly setbacks.
Cautionary Notes: Fundamental challenges persist, including a 36.8% decline in quarterly PAT and a 7.63% contraction in net sales, which weigh on the company’s quality rating. Monthly technical indicators remain bearish, signalling that longer-term downtrend pressures have not fully abated. Institutional interest is minimal, with domestic mutual funds holding only 0.01%, reflecting subdued confidence. The stock’s one-year return of -2.95% trails the Sensex’s 6.66%, highlighting ongoing underperformance over extended periods.
Considering Novartis India Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
Conclusion
Novartis India Ltd’s performance in the week ending 6 February 2026 reflects a complex interplay of technical improvement and fundamental caution. The upgrade to a 'Sell' rating from 'Strong Sell' and the accompanying 8.57% price appreciation signal a tentative stabilisation and short-term momentum shift. However, persistent financial challenges and mixed technical signals on monthly charts counsel prudence.
Investors should note the stock’s relative outperformance against the Sensex in the near term, but also remain mindful of the limited institutional backing and subdued long-term returns. The current Mojo Score of 31.0 and Sell grade suggest that while the stock may be emerging from a downtrend, it is not yet positioned for accumulation. Continued monitoring of technical indicators and quarterly results will be essential to assess whether this momentum can be sustained.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
